A multidimensional company committed to rethinking the standard approach to traditional pharmaceutical applications.

With globally patented technology, Sentar is paving the way for development of new pharmaceutical products.

Sentar has identified an initial portfolio of 15 generic pharmaceutical compounds utilizing our patented TABMELT® technology.